We evaluated the efficacy and safety of istradefylline, a selective adenosine A2A receptor antagonist administered as adjunctive treatment to levodopa for 12 weeks in a double-blind manner in Parkinson’s disease patients with motor complications in Japan.
Articles Collection
- This article collection was made possible by Cynapsus.
Footer
Copyright © 1999-2024 John Wiley & Sons, Inc. All Rights Reserved.
